Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number Sort ascending | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| PAR-23-193 | April 4, 2026 | X01 | Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) |
| PAR-23-192 | May 3, 2025 | X01 | Biological Testing Facility (X01 Clinical Trial Not Allowed) |
| PAR-23-180 | December 8, 2024 | R01 | Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
| PAR-23-171 | May 16, 2025 | X01 | Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) |
| PAR-23-166 | August 8, 2026 | S06 | Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) |
| PAR-23-160 | October 18, 2024 | R03 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) |
| PAR-23-159 | October 18, 2024 | R21 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
| PAR-23-137 | June 7, 2025 | R25 | NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) |
| PAR-23-131 | May 8, 2026 | R21 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
| PAR-23-130 | May 8, 2026 | R01 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) |
| PAR-23-128 | May 3, 2025 | X01 | Biological Testing Facility (X01 Clinical Trial Not Allowed) |
| PAR-23-122 | May 8, 2026 | R01 | Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) |
| PAR-23-120 | May 16, 2025 | X01 | Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) |
| PAR-23-117 | August 5, 2025 | P30 | Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
| PAR-23-116 | August 5, 2025 | P30 | Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
| PAR-23-114 | January 17, 2026 | R25 | Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed) |
| PAR-23-112 | January 8, 2026 | R01 | Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) |
| PAR-23-075 | January 8, 2026 | R03 | Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) |
| PAR-23-074 | January 8, 2026 | R01 | In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
| PAR-23-067 | January 8, 2026 | R21 | Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed) |
BACK TO TOP